Serum thrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis
- PMID: 9184382
Serum thrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis
Abstract
Thrombopoietin (Tpo) regulates platelet production, but the mechanisms regulating the serum Tpo level and platelet count in circulation have been a subject of debate. Tpo was reported to be expressed mainly in liver and kidney, but we found that Tpo is expressed in all tissues examined: abundantly in liver, kidney, muscle, colon, brain and intestine, and moderately in bone marrow, spleen, lung, stomach, heart, thymus, ovary, and endothelial and leukemic cell lines. The levels of Tpo transcripts in major Tpo producing organs, liver and kidney, and in the platelet production sites bone marrow and spleen, were constant during acute thrombocytopenia induced by anti-platelet monoclonal antibody administration in mice, and during thrombocytosis induced by Tpo injection. Furthermore, we noticed that platelet count is not exactly inversely proportional to serum Tpo level. During acute thrombocytopenia, serum Tpo level transiently increased a few hours after antibody injection, and returned to the basal level just when matured megakaryocytes accumulated in bone marrow and spleen but the platelet count was still low. Matured megakaryocytes in bone marrow and spleen increased when the serum Tpo level decreased, and decreased when platelet count rebounded. Taken together with other observations, we propose here a modified version of Kuter and Rosenberg's theory, that is, Tpo is constitutively expressed in a variety of organs throughout the body, even in acute thrombocytopenia and thrombocytosis, and that the serum Tpo level is not regulated by Tpo gene expression nor only by platelet counts in circulation, but by the total counts of both megakaryocytes in bone marrow and spleen and of platelets in circulation.
Similar articles
-
Evaluation of thrombopoiesis in thrombocytopenic disorders by simultaneous measurement of reticulated platelets of whole blood and serum thrombopoietin concentrations.Thromb Haemost. 1998 Jun;79(6):1106-10. Thromb Haemost. 1998. PMID: 9657432
-
The physiology of platelet production.Stem Cells. 1996;14 Suppl 1:88-101. doi: 10.1002/stem.5530140711. Stem Cells. 1996. PMID: 11012207 Review.
-
Bloodstream thrombopoietin in rheumatoid arthritis with thrombocytosis.Clin Rheumatol. 2002 Nov;21(6):453-6. doi: 10.1007/s100670200114. Clin Rheumatol. 2002. PMID: 12447626
-
The diagnostic value of thrombopoietin level measurements in thrombocytopenia.Thromb Haemost. 1998 Jun;79(6):1101-5. Thromb Haemost. 1998. PMID: 9657431
-
An overview of thrombopoietin: with a historical perspective.C R Acad Sci III. 1995 May;318(5):609-18. C R Acad Sci III. 1995. PMID: 7671007 Review.
Cited by
-
Thrombopoietin and its receptor in normal and neoplastic hematopoiesis.Thromb J. 2016 Oct 4;14(Suppl 1):40. doi: 10.1186/s12959-016-0095-z. eCollection 2016. Thromb J. 2016. PMID: 27766065 Free PMC article.
-
Protective Effects of Chronic Intermittent Hypobaric Hypoxia Pretreatment against Aplastic Anemia through Improving the Adhesiveness and Stress of Mesenchymal Stem Cells in Rats.Stem Cells Int. 2017;2017:5706193. doi: 10.1155/2017/5706193. Epub 2017 Jul 16. Stem Cells Int. 2017. PMID: 28798776 Free PMC article.
-
Increased plasma thrombopoietin levels in patients with myelodysplastic syndrome: a reliable marker for a benign subset of bone marrow failure.Haematologica. 2013 Jun;98(6):901-7. doi: 10.3324/haematol.2012.066217. Epub 2013 Feb 12. Haematologica. 2013. PMID: 23403320 Free PMC article.
-
Correlation between thrombopoietin and inflammatory factors, platelet indices, and thrombosis in patients with sepsis: A retrospective study.World J Clin Cases. 2022 May 6;10(13):4072-4083. doi: 10.12998/wjcc.v10.i13.4072. World J Clin Cases. 2022. PMID: 35665097 Free PMC article.
-
Severe Clinical Course in a Patient with Congenital Amegakaryocytic Thrombocytopenia Due to a Missense Mutation of the c-MPL Gene.Turk J Haematol. 2015 Jun;32(2):172-4. doi: 10.4274/tjh.2013.0191. Turk J Haematol. 2015. PMID: 26316487 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources